A carregar...
Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells
INTRODUCTION: Tamoxifen is a drug of choice for endocrine-responsive breast tumor patients. However, tamoxifen resistance has become a major concern for the treatment of breast cancer. Combinational therapies of tamoxifen and different drugs are being frequently studied. In the current study, we tes...
Na minha lista:
| Publicado no: | Anticancer Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378591/ https://ncbi.nlm.nih.gov/pubmed/19966541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e328333d557 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|